Nucleate Michigan X MBVF Venture Series Lecture 4

​​Join Nucleate Michigan and the Michigan Biomedical Venture Fund (MBVF) for the fourth event in our Venture Capital Lecture Series, exploring how investors evaluate, fund, and build life science startups from concept to clinic.

​This session features Matthew Hymes, managing Director at i5 BioPartners. Matthew is a life sciences leader with 15+ years of experience in genomic and molecular diagnostics. He has led successful product launches, built global distribution networks, and developed strategic partnerships that expand markets and drive growth.

​Matthew will discuss how to communicate the value of complex technologies and collaborate accross scientific and business teams.

​About the Host:​

​​Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information, and visit https://nucleate.org/privacy-policy/ to read our privacy policy.

​​We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!

​​Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma 

​​Philanthropic Support: Lyda Hill Philanthropies

​​Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout, Browne Consulting

​​In-Kind Support: AcademicLabs, Lens.org, SynBioBeta